Advaxis, Inc. Stock Price - ADXS

Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
CHART Trader
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Advaxis, Inc. ADXS NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.134212 -35.6% 0.242788 0.2835 0.222 0.2835 0.377 15:24:55
Bid Price Ask Price Spread Spread % News
0.2425 0.245 0.0025 1.02% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,498 3,673,445 $ 0.2429 $ 892.32k 612.39k 0.22 - 3.58
Last Trade Time Type Quantity Stock Price Currency
15:24:50 1,500 $0.24 USD
Industry Sector

Advaxis, Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 16.96M 69.5M $ -93.44M -2.31 0.00 41.4M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 0.00 0.00% 20.88k 30.20%

more financials information »

Advaxis, Inc. News

Latest ADXS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADXS Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.3990.40780.2220.3700320k4M409k-0.156212-39.15%
1 Month0.450.5090.2220.423768k4M429k-0.207212-46.05%
3 Months0.83350.970.2220.634468k4M571k-0.590712-70.87%
6 Months1.681.810.2221.044468k9M767k-1.437212-85.55%
1 Year3.063.580.2221.698868k9M826k-2.817212-92.07%
3 Years12.116.2950.2225.982268k9M794k-11.857212-97.99%
5 Years4.2530.130.2229.06973k9M803k-4.007212-94.29%

Advaxis, Inc. Description

Advaxis Incorporated is a clinical development stage biotechnology company, developing safe & effective immunotherapies for cancer & infectious diseases with its main construct, ADXS-HPV, being evaluated in 5 clinical trials for HPV-associated diseases.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.